Literature DB >> 9820139

Molecular analysis of human parechovirus type 2 (formerly echovirus 23).

F Ghazi1, P J Hughes, T Hyypiä, G Stanway.   

Abstract

Picornaviruses have been divided into five genera until recently, when a sixth genus, Parechovirus, was defined. Human parechovirus type 1 (HPeV1; formerly echovirus 22) was the first recognized member of this genus and preliminary sequence analysis of echovirus 23 [now renamed human parechovirus type 2 (HPeV2)] suggested that it is also a parechovirus. Here we describe the complete nucleotide and predicted amino acid sequences of HPeV2, which indicate a close relationship to HPeV1 throughout the genome. Sequence covariance in the 5' untranslated region allows a prediction of the secondary structure, which indicates that these parechoviruses have a type 2 internal ribosome entry site, most closely related to that of cardioviruses. Overall, HPeV2 has 87.9% amino acid identity with HPeV1, most divergence being seen in regions of the capsid proteins that probably define antigenic sites. The N-terminal sequence extension to VP3, seen only in parechoviruses, is highly basic in both viruses, but has a variable sequence, suggesting that it does not have a sequence-specific role. There is an RGD motif near the C terminus of VP1, in an analogous location to that in HPeV1 which is believed to be functionally significant. The results confirm that both viruses are parechoviruses and give insights into the molecular features of this genus.

Entities:  

Mesh:

Year:  1998        PMID: 9820139     DOI: 10.1099/0022-1317-79-11-2641

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  41 in total

1.  Conserved RNA secondary structures in Picornaviridae genomes.

Authors:  C Witwer; S Rauscher; I L Hofacker; P F Stadler
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Construction of an infectious cDNA clone of Aichi virus (a new member of the family Picornaviridae) and mutational analysis of a stem-loop structure at the 5' end of the genome.

Authors:  J Sasaki; Y Kusuhara; Y Maeno; N Kobayashi; T Yamashita; K Sakae; N Takeda; K Taniguchi
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases.

Authors:  Jeremy A Bruenn
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

5.  The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis.

Authors:  Shigeo Nagashima; Jun Sasaki; Koki Taniguchi
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains.

Authors:  Mohammed Al-Sunaidi; Cigdem H Williams; Pamela J Hughes; David P Schnurr; Glyn Stanway
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  Identification of potential recombination breakpoints in human parechoviruses.

Authors:  Jan Zoll; Jochem M D Galama; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Molecular analysis of three Ljungan virus isolates reveals a new, close-to-root lineage of the Picornaviridae with a cluster of two unrelated 2A proteins.

Authors:  Susanne Johansson; Bo Niklasson; Jacob Maizel; Alexander E Gorbalenya; A Michael Lindberg
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Replication complex of human parechovirus 1.

Authors:  Camilla Krogerus; Denise Egger; Olga Samuilova; Timo Hyypiä; Kurt Bienz
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Isolation and characterization of novel human parechovirus from clinical samples.

Authors:  Kanako Watanabe; Masayasu Oie; Masaya Higuchi; Makoto Nishikawa; Masahiro Fujii
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.